Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Department of Defense's Defense Health Agency is seeking vendors to provide Basophil Activation Testing (BAT) services for allergy diagnostics at Walter Reed Medical Center. Vendors must utilize validated flow cytometry in a CLIA-certified laboratory, offering various BAT panel configurations for multiple allergens. All testing must be FDA-approved, with results delivered within five business days. Interested parties should submit a capabilities document detailing relevant experience.
Walter Reed Medical Center is looking for a vendor that can provide diagnostic Basophil Activation Testing (BAT) services using validated flow cytometry or equivalent methodologies. Testing must be performed in a Clinical Laboratory Improvement Amendments (CLIAC) certified laboratory, and the contractor shall offer a variety of BAT panel configurations including screening and comprehensive testing, with the flexibility to accommodate up to 10 allergen triggers for food, environmental, drug, venom, and miscellaneous allergens per patient encounter. All testing methodologies must be FDA-approved. If capability exists, results are expected to be provided within clinically acceptable turnaround time of 5 business days.
Requirements:
- Support both screening (10-allergen panels) and confirmatory (graded concentration) panels
- Maintain HIPAA compliance and secure data exchange
- Maintain CLIA certification and ensure all tests used are FDA-approved throughout the agreement period
If your company posseses this capability and has relevant experience, please provide this office with your capabilities document outlining your experience.
BASOPHIL ACTIVATION TESTING (BAT) FOR ALLERGY DIAGNOSTICS is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.